---
title: How to Apply MDR Classification Rule 7: Short-Term Surgically Invasive Devices
description: MDR Annex VIII Rule 7 classifies surgically invasive devices intended for short-term use. Here is how to apply it.
authors: Tibor Zechmeister, Felix Lenhard
category: Device Classification & Conformity
primary_keyword: MDR Rule 7 short-term surgically invasive
canonical_url: https://zechmeister-solutions.com/en/blog/mdr-rule-7-short-term-surgically-invasive
source: zechmeister-solutions.com
license: All rights reserved. Content may be cited with attribution and a link to the canonical URL.
---

# How to Apply MDR Classification Rule 7: Short-Term Surgically Invasive Devices

*By Tibor Zechmeister (EU MDR Expert, Notified Body Lead Auditor) and Felix Lenhard.*

> **Rule 7 of Annex VIII of Regulation (EU) 2017/745 classifies surgically invasive devices intended for short-term use — that is, devices that penetrate the body surface or a body orifice in the context of a surgical operation and are normally intended for continuous use of more than 60 minutes and not more than 30 days. The default class under Rule 7 is Class IIa, with escalations to Class IIb or Class III depending on the anatomical site, the energy delivered, biological effects, absorption, chemical change, and medicinal product administration. Classification under Rule 7 is governed by MDR Article 51, and the authoritative interpretation guide is MDCG 2021-24 (October 2021).**

**By Tibor Zechmeister and Felix Lenhard. Last updated 10 April 2026.**

---

## TL;DR

- Rule 7 catches surgically invasive devices intended for short-term use — continuous intended use of more than 60 minutes but not more than 30 days.
- Default class under Rule 7 is Class IIa.
- Escalations to Class III apply for direct contact with the heart, central circulatory system, or central nervous system.
- Escalations to Class IIb apply for ionising radiation, biological effect or absorption, chemical change in the body, medicinal product administration in a potentially hazardous way, and substances that are absorbed or locally dispersed.
- Short-term is a duration band, not a product lifetime. The clock runs on continuous intended use, as defined in Section 1 of Annex VIII.
- The two most common Rule 7 mistakes are treating "short-term" as calendar time and missing an escalation that bumps the class from IIa to IIb or III.

---

## Why Rule 7 matters

Rule 7 is the middle rule in the surgically invasive family (Rules 6, 7, 8). Rule 6 covers transient use. Rule 7 covers short-term use. Rule 8 covers long-term and implantable devices. The three rules share similar escalation conditions but differ on the duration band, and the duration band is what determines which rule applies to your device in the first place.

For a startup, Rule 7 matters because it sits at the boundary where a lot of procedural devices live. Drainage catheters used for a few days after surgery. Temporary fixation devices used during a hospital stay. Cannulas and introducers left in place between procedures. These are the devices where a misread of "short-term" pushes the classification into the wrong rule and the wrong class. A device that should be in Rule 7 as Class IIa ends up over-scoped at Class IIb because someone assumed Rule 8 applied, or under-scoped at Class I because someone assumed Rule 5 applied. Both outcomes waste runway.

The previous post in this series, [MDR Annex VIII classification rules: the complete guide](/blog/mdr-annex-viii-classification-rules-complete-guide), walks through all twenty-two rules. This post zooms into Rule 7 and shows how to apply it to a real device.

## Rule 7 text, decoded

Rule 7 of Annex VIII of Regulation (EU) 2017/745 applies to surgically invasive devices intended for short-term use. The default classification is Class IIa. Five escalation conditions move that default to a higher class:

- **Class III** — if the device is specifically intended to diagnose, monitor, or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body.
- **Class III** — if the device is specifically intended for use in direct contact with the central nervous system.
- **Class IIb** — if the device is specifically intended to supply energy in the form of ionising radiation.
- **Class IIb** — if the device is intended to have a biological effect or to be wholly or mainly absorbed.
- **Class IIb** — if the device is intended to administer medicinal products by means of a delivery system, if this is done in a manner that is potentially hazardous taking account of the mode of application.
- **Class IIb** — if the device is intended to undergo chemical change in the body, except for devices placed in the teeth.

Work through these in order. If none apply, the device is Class IIa. If one applies, take the class it produces. If more than one applies, the highest class wins — that is the implementing rule in Section 2 of Annex VIII, and it governs Rule 7 the same way it governs every other rule.

The authoritative interpretation of Rule 7 is MDCG 2021-24 (October 2021), which walks through the surgically invasive family with examples. Read it alongside the Regulation text. Do not classify a Rule 7 device from memory.

## What "short-term" actually means

Duration bands in Annex VIII are defined in Section 1 of the same annex. There are three of them for the invasive family: transient (normally intended for continuous use for less than 60 minutes), short-term (normally intended for continuous use for more than 60 minutes and not more than 30 days), and long-term (normally intended for continuous use for more than 30 days).

The critical word is **continuous**. Continuous intended use is not product lifetime. It is the uninterrupted duration for which the device is intended to remain in place during a single use. A drainage catheter placed for three days after surgery is short-term. A biopsy needle used for twenty minutes is transient. A reusable surgical instrument used for thirty minutes per procedure across many procedures is transient — the clock resets each procedure, because the device is not in continuous contact with the patient between uses.

Section 1 also contains two interpretive notes that matter for Rule 7. First, if a device is intended to be used again, and the total continuous use across the intended uses crosses a duration threshold, the longer duration applies. Second, if the device is intended to be replaced by another identical device within a short period, the uses are considered continuous and the durations are added. These rules prevent the classic reclassification game of "it's only transient, we just leave it in for a week by swapping it out every hour." That game does not work under Annex VIII.

If your device sits exactly on the 60-minute or 30-day boundary, document your reasoning. Write down the intended continuous use duration, where it is stated (the label, the IFU, the clinical evaluation), and why that duration puts you in Rule 7 rather than Rule 6 or Rule 8. A Notified Body auditor will ask for this reasoning and will not accept "around an hour."

## What "surgically invasive" actually means

Section 1 of Annex VIII defines an invasive device as a device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body. It defines a surgically invasive device as an invasive device which penetrates inside the body through the surface of the body, with the aid or in the context of a surgical operation, and a device that produces penetration other than through a body orifice.

Two elements matter. First, the device must penetrate the surface of the body — skin, or an equivalent bounded anatomical surface. Second, the penetration must happen with the aid or in the context of a surgical operation. A device that enters through a natural orifice without surgery is Rule 5, not Rule 7. A device that penetrates the skin in a non-surgical context (for example, a simple hypodermic injection) is still surgically invasive under Annex VIII, because the definition explicitly covers penetration through the surface of the body. MDCG 2021-24 treats hypodermic needles as surgically invasive for classification purposes and walks through the examples.

The other trap here is partial penetration. A device that sits on the skin but has an element that penetrates — a sensor with a subcutaneous lead, an adhesive patch with a microneedle array — is surgically invasive with respect to the penetrating component. The classification then follows the most invasive part, not the bulk of the device.

## Rule 7 escalation conditions, one by one

The escalation conditions are where Rule 7 devices actually get classified, because the Class IIa default is frequently displaced.

**Heart and central circulatory system.** Any device intended to diagnose, monitor, or correct a defect of the heart or central circulatory system through direct contact with these parts of the body jumps to Class III under Rule 7. "Direct contact" is the key phrase. A device that works in the arm does not meet this condition. A device that reaches into the aorta, the coronary arteries, or the chambers of the heart does. Section 1 of Annex VIII defines the central circulatory system with a specific list of vessels — know the list, or you will either over-escalate or under-escalate.

**Central nervous system.** Direct contact with the central nervous system — brain, spinal cord, meninges — moves the device to Class III under Rule 7. Peripheral nerves do not count here. Again, Section 1 has the definition.

**Ionising radiation.** A device that is specifically intended to supply energy in the form of ionising radiation moves to Class IIb. This covers brachytherapy seeds used short-term, certain radioactive probes, and similar devices.

**Biological effect or absorption.** A device intended to have a biological effect — beyond the mechanical or physical effect of being there — moves to Class IIb. Same for devices intended to be wholly or mainly absorbed. A bioresorbable short-term implant is the canonical example.

**Medicinal product administration.** A device that administers a medicinal product via a delivery system moves to Class IIb if the administration is potentially hazardous given the mode of application. Short-term infusion devices are the typical example — the hazard depends on what is infused, where, and how.

**Chemical change in the body.** A device intended to undergo chemical change in the body moves to Class IIb, with the explicit exception for devices placed in the teeth. Dental amalgams, resin composites, and similar tooth-placed devices are the exception; everything else that chemically transforms in situ is escalated.

Walk through all six conditions for every Rule 7 device. Write each one down. If none apply, state that explicitly and land on Class IIa. A written walkthrough is the single best protection against a Notified Body challenge during conformity assessment.

## Examples of Rule 7 devices

Short-term post-operative drainage catheters. Temporary fixation pins used during a hospital admission and removed before discharge. Cannulas left in place between linked procedures. Biliary drainage catheters placed for a period of days. Short-term peripheral nerve stimulator leads. Short-term introducer sheaths that remain across sequential interventions.

Each of these lands at Class IIa by default under Rule 7, then needs checking against the escalation conditions. A drainage catheter that does nothing but drain fluid stays at IIa. The same catheter redesigned to release an antimicrobial agent may jump to IIb under the biological effect condition. A drainage catheter routed through the coronary sinus for short-term monitoring of the central circulatory system jumps to III. The device did not change shape; the intended purpose, documented per Article 2(12) of the Regulation, changed the classification.

## Common misclassifications under Rule 7

**Treating "short-term" as product lifetime.** A device sold for years of clinical use but intended for continuous use of three days per procedure is short-term. A device intended to remain in place for 45 days of continuous use is long-term — Rule 8, not Rule 7.

**Treating partial skin penetration as non-invasive.** A patch with a microneedle array is surgically invasive with respect to the penetrating component. Rule 4 does not apply.

**Missing the heart or CNS escalation because the contact is "brief."** The Rule 7 escalations do not have a minimum contact duration. Direct contact is direct contact.

**Assuming Rule 5 covers it because the device enters through an orifice.** Rule 5 covers invasive devices with respect to body orifices that are not surgically invasive. A surgical procedure using the orifice as an access route makes the device surgically invasive, and Rules 6, 7, or 8 apply.

**Landing at IIa without checking every escalation.** A rigorous Rule 7 classification walks through all six escalation conditions in writing, not just the first one that does not apply.

## The Subtract to Ship angle on Rule 7

The [Subtract to Ship framework for MDR compliance](/blog/subtract-to-ship-framework-mdr) treats classification as the second pass, after intended purpose and before evidence. Rule 7 is a rule where the subtraction discipline pays off because the escalation conditions are narrow and specific. A device correctly classified at IIa under Rule 7 has a very different workload from a device incorrectly classified at IIb or III, and the difference is entirely about whether the specific escalation language in the rule actually applies to the device you have.

Subtraction here means refusing to over-classify out of caution. "We'll just call it IIb to be safe" is not conservatism — it is runway waste. Conservatism is applying the rule correctly, in writing, with a citation to the specific escalation condition that does or does not apply, and defending the result. If the result is IIa, ship as IIa. If the result is IIb or III because an escalation applies, scope the project accordingly. Neither direction is ever a feeling.

## Reality Check — How well do you know Rule 7 for your device?

1. Is your device surgically invasive under the Section 1 definition, not just "penetrates something"?
2. Is your intended continuous use duration more than 60 minutes and not more than 30 days, documented and defensible?
3. Have you walked through all six Rule 7 escalation conditions in writing?
4. If your device touches the heart, central circulatory system, or central nervous system, is the contact "direct" under the Section 1 definitions?
5. Have you cross-checked your Rule 7 classification against MDCG 2021-24?
6. Can you cite the specific paragraph of Rule 7 that lands your device at its class?
7. If a Notified Body auditor asked tomorrow, could you defend the class in one paragraph with a rule citation?

## Frequently Asked Questions

**What is the default class under MDR Rule 7?**
The default class under Rule 7 is Class IIa. Rule 7 applies to surgically invasive devices intended for short-term use, meaning continuous intended use of more than 60 minutes and not more than 30 days. The default is displaced only when one of the escalation conditions in Rule 7 applies, such as direct contact with the heart, central circulatory system, or central nervous system, or delivery of ionising radiation, biological effect, absorption, chemical change, or hazardous medicinal product administration.

**What does "short-term" mean in Annex VIII?**
Short-term is defined in Section 1 of Annex VIII as normally intended for continuous use for more than 60 minutes and not more than 30 days. The duration is measured as continuous intended use, not as product lifetime. If a device is intended to be used again, or replaced by another identical device within a short period, the durations may be added under the interpretive notes in Section 1.

**When does Rule 7 escalate a device to Class III?**
Rule 7 escalates a device to Class III if it is specifically intended to diagnose, monitor, or correct a defect of the heart or central circulatory system through direct contact, or if it is specifically intended for direct contact with the central nervous system. Both escalations require direct anatomical contact as defined in Section 1 of Annex VIII. Devices that reach the heart through the arm without direct contact with the heart itself do not trigger the Class III escalation.

**How is Rule 7 different from Rule 6 and Rule 8?**
All three rules cover surgically invasive devices. The difference is the duration band. Rule 6 covers transient devices (less than 60 minutes continuous use). Rule 7 covers short-term devices (60 minutes to 30 days). Rule 8 covers long-term devices (more than 30 days) and implantable devices. The escalation conditions are similar but not identical across the three rules, and Rule 8 carries additional Class III escalations for implants in the heart, spine, and joints.

**Is a hypodermic needle a Rule 7 device?**
A hypodermic needle used for a brief injection is transient, not short-term, and falls under Rule 6. A similar device left in place for more than 60 minutes of continuous use — for example, an indwelling needle for short-term access — moves into Rule 7. The duration of continuous intended use is the dividing line, and it must be stated in the intended purpose under Article 2(12) of the Regulation.

## Related reading

- [The Subtract to Ship framework for MDR compliance](/blog/subtract-to-ship-framework-mdr) — the methodology that treats classification as the second of four passes.
- [MDR device classification explained](/blog/mdr-device-classification-explained) — the pillar post on how classification works across all four classes.
- [MDR Annex VIII classification rules: the complete guide](/blog/mdr-annex-viii-classification-rules-complete-guide) — the rule-by-rule walkthrough for all twenty-two rules.
- [How to apply MDR classification Rule 5: invasive devices with respect to body orifices](/blog/mdr-rule-5-body-orifice-invasive) — the neighbouring rule for non-surgical orifice-invasive devices.
- [How to apply MDR classification Rule 6: transient surgically invasive devices](/blog/mdr-rule-6-transient-surgically-invasive) — the shorter-duration sibling of Rule 7.
- [How to apply MDR classification Rule 8: long-term and implantable devices](/blog/mdr-rule-8-long-term-implantable) — the longer-duration sibling of Rule 7.
- [Seven classification mistakes startups make under the MDR](/blog/7-classification-mistakes-startups-make-under-mdr) — the failure modes to avoid.

## Sources

1. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, Article 2(12) (intended purpose), Article 51 (classification), Annex VIII Section 1 (definitions of invasive, surgically invasive, and duration bands), Annex VIII Section 2 (implementing rules), Annex VIII Section 3 Rule 7 (short-term surgically invasive devices). Official Journal L 117, 5.5.2017.
2. MDCG 2021-24 — Guidance on classification of medical devices, October 2021.

---

*This post is part of the Device Classification & Conformity Assessment series in the Subtract to Ship: MDR blog. Authored by Felix Lenhard and Tibor Zechmeister. The Rule 7 walkthrough above is the orientation layer — the actual classification of a specific device must always be made against the full text of Annex VIII, cross-checked with MDCG 2021-24, and documented with a specific rule citation.*

---

*This post is part of the [Device Classification & Conformity](https://zechmeister-solutions.com/en/blog/category/classification) cluster in the [Subtract to Ship: MDR Blog](https://zechmeister-solutions.com/en/blog). For EU MDR certification consulting, see [zechmeister-solutions.com](https://zechmeister-solutions.com).*